Chemotherapy-resistant intravascular lymphoma accompanied by ADAMTS13 inhibitor successfully treated with rituximab

International Journal of Hematology

Volumn 88, Issue 3, 2008, Pages 345-347

  Kanno, Masatoshi ^a   Nakamura, Shinobu ^b   Kawahara, Makoto ^b   Ueno, Satoshi ^b   Nakamine, Hirokazu ^b   Matsumoto, Masanori ^b   Fujimura, Yoshihiro ^b  

^a NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; METALLOPROTEINASE INHIBITOR; PREDNISOLONE; RITUXIMAB; SOLUBLE INTERLEUKIN 2 RECEPTOR; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABSENCE OF SIDE EFFECTS; ADULT; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CANCER THERAPY; CASE REPORT; CAUSE OF DEATH; CONVULSION; DRUG MEGADOSE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LETTER; LUNG BIOPSY; MALE; MENTAL DISEASE; MULTIPLE CYCLE TREATMENT; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT RESPONSE;

ADAM PROTEINS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 60049096141     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0143-y     Document Type: Letter

References (10)

1. M Kawahara M Kanno M Matsumoto S Nakamura Y Fujimura S Ueno 2004 Diffuse neurodeficits in intravascular lymphomatosis with ADAMTS13 inhibitor Neurology 63 1731 3
2. 18F-fluorodeoxyglucose positron emission tomography. Int J Hematol. 2008. doi: 10.1007/s12185-008-0102- 7
3. T Murase M Yamaguchi R Suzuki 2007 Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5 Blood 109 478 85
4. H Sill G Hofler P Kaufmann 1995 Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura) Cancer 75 1167 70
5. I Takacs N Eros I Bene 2004 Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy Ann Hematol 83 608 10
6. F Jardin F Callonnec N Contentin 2005 Intravascular large B-cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen Clin Lymphoma 6 46 9
7. L Bazhenova P Higginbottom J Mason 2006 Intravascular lymphoma: a role for single-agent rituximab Leuk Lymphoma 47 337 41
8. T Murase S Nakamura K Kawaguchi 2000 An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with hemophagocytic syndrome Br J Haematol 111 826 34
9. SJ Wu WC Chou BS Ko HF Tien 2007 Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma Haematologica 92 141 2
10. H Imai K Kajimoto M Taniwaki 2004 Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases Pathol Int 54 231 6